Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
famciclovir + gabapentin
- Development stage
- Unknown
- Lead developer
- Novartis
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
A combination therapy consisting of the antiviral agent famciclovir and the anticonvulsant gabapentin, utilized in the management of acute herpes zoster (shingles) and the prevention or treatment of postherpetic neuralgia (PHN). Famciclovir is a prodrug of penciclovir that inhibits viral DNA polymerase, thereby suppressing viral replication. Gabapentin acts by binding to the alpha-2/delta-1 subunit of voltage-gated calcium channels in the central nervous system, modulating the release of excitatory neurotransmitters to alleviate neuropathic pain. This specific combination is being studied by investigator Xiaguang Duan in clinical trials evaluating the additive efficacy of multimodal nerve blocks and pulsed radiofrequency for severe zoster-associated pain.
- Other names
- famciclovir and gabapentin
02
Targets
CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)CACNA2D2 (α2δ-2)DNA polymerase family
Beyond the preview
Go deeper on famciclovir + gabapentin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on famciclovir + gabapentin.